Morocco Pharmaceuticals and Healthcare Report Q2 2013


April 17, 2013
102 Pages - SKU: BMI5020867
License type:
Countries covered: Morocco

BMI View: While Morocco’s pharmaceutical market is small in absolute terms, its forward growthtrajectory is encouraging. Positive drivers include population growth and changing epidemiologicalprofile, as well as the authorities’ efforts to improve healthcare coverage and services. However, factorssuch as the lack of qualified healthcare staff and large sections of low-income population will continue tohamper a more effective uptake of pharmaceuticals, although imports will continue to dominate.

Headline Expenditure Projections

Pharmaceuticals: MAD10.19bn (US$1.30bn) in 2012 to MAD12.27bn (US$1.46bn) in 2013;+9.7% in local currency terms and +12.8% in US dollar terms. Forecast broadly unchangedfrom Q113.

Healthcare: MAD46.24bn (US$5.35bn) in 2012 to MAD49.99bn (US$5.95bn) in 2013; +8.1%in local currency terms and +11.2% in US dollar terms. Forecast broadly unchanged fromQ113.



More Prescription Drugs reports by Business Monitor International

Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
See all reports like this >>

More Morocco Prescription Drugs reports

Antibiotics Market in Morocco to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Morocco. The study provides essential market ...
The Pharmaceutical Market: Morocco by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Morocco Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: Morocco’s pharmaceutical and healthcare market developments this year will be shaped by the delayed rollout of the national health insurance scheme. On the ...
The Pharmaceutical Market: Morocco (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Morocco reports

D&B Country RiskLine Report: Morocco by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Morocco by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Morocco: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis on Morocco, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
See all reports like this >>